Accuray (NASDAQ:ARAY – Get Rating) and Apollo Endosurgery (NASDAQ:APEN – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, risk, earnings, valuation, institutional ownership and dividends. Valuation and Earnings This table compares Accuray and Apollo Endosurgery’s […]
Accuray (NASDAQ:ARAY – Get Rating) and Apollo Endosurgery (NASDAQ:APEN – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, valuation and profitability. Institutional and Insider Ownership 63.4% of Accuray shares are owned […]
Apollo Endosurgery (NASDAQ:APEN – Get Rating) and Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation. Analyst Ratings This is a breakdown of current ratings […]
Shares of Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $8.19 and traded as high as $9.93. Apollo Endosurgery shares last traded at $9.89, with a volume of 821,386 shares trading hands. Analyst Ratings Changes A number […]
Wall Street brokerages forecast that Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) will announce earnings per share of ($0.21) for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Apollo Endosurgery’s earnings. The highest EPS estimate is ($0.16) and the lowest is ($0.27). Apollo Endosurgery reported earnings per share of […]